Matches in Wikidata for { <http://www.wikidata.org/entity/Q91754835> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q91754835 description "article scientifique publié en 2019" @default.
- Q91754835 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q91754835 description "scientific article published on 04 May 2019" @default.
- Q91754835 description "wetenschappelijk artikel" @default.
- Q91754835 description "наукова стаття, опублікована 4 травня 2019" @default.
- Q91754835 name "Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial" @default.
- Q91754835 name "Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial" @default.
- Q91754835 type Item @default.
- Q91754835 label "Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial" @default.
- Q91754835 label "Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial" @default.
- Q91754835 prefLabel "Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial" @default.
- Q91754835 prefLabel "Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial" @default.
- Q91754835 P1433 Q91754835-1674194E-D34E-49B5-90FC-48AC824E0187 @default.
- Q91754835 P1476 Q91754835-2C25E86C-2C57-4532-9C50-ED39F8788F6A @default.
- Q91754835 P2093 Q91754835-3F9E2D10-F4A4-4B29-9AF6-AA4314D198F0 @default.
- Q91754835 P2093 Q91754835-494CE09A-5D4C-4054-A90B-4D131DC21D96 @default.
- Q91754835 P2093 Q91754835-BFC388D8-C1B7-4AAF-8518-26E05804DAF9 @default.
- Q91754835 P304 Q91754835-4D4FE461-DDF9-4FAA-BDEA-A47B9222A4EF @default.
- Q91754835 P31 Q91754835-62391F60-1070-4913-B640-41CD8F558BDE @default.
- Q91754835 P356 Q91754835-B76C923E-361C-4767-BF55-E6EB84AAF873 @default.
- Q91754835 P433 Q91754835-287DD6D0-3CE3-4C5A-9443-93FCD25FEBC4 @default.
- Q91754835 P478 Q91754835-315FC2D6-5218-4F14-85DF-889FB72DF80A @default.
- Q91754835 P50 Q91754835-0210FD05-55FD-4BBB-ABC6-28AC34AEA71D @default.
- Q91754835 P50 Q91754835-1BC68A8A-7B3B-464C-AFA8-26FA92C1F37E @default.
- Q91754835 P50 Q91754835-20A0FD81-B709-47B1-AE70-66B98984909C @default.
- Q91754835 P50 Q91754835-3ACEF6EE-FE7E-42FE-AF8F-8E013D5EB9C5 @default.
- Q91754835 P50 Q91754835-4263308E-5168-4EC6-A5AD-3518DD2AD867 @default.
- Q91754835 P50 Q91754835-4B8A5483-DD63-41E6-A302-28C508429562 @default.
- Q91754835 P50 Q91754835-5033419C-82C5-4061-A940-352884F4DE07 @default.
- Q91754835 P50 Q91754835-57CB6EAE-1D89-444E-8490-57C82D18B13A @default.
- Q91754835 P50 Q91754835-8578D087-58F6-4690-877D-F076017EE864 @default.
- Q91754835 P50 Q91754835-890FCDD2-F3A6-47E5-A091-907A879E7A4F @default.
- Q91754835 P50 Q91754835-A5C20BF2-BBEE-49F9-B3DE-685D76EFC10C @default.
- Q91754835 P50 Q91754835-BE6ACFDF-5FA2-4756-A934-EE9E9516F164 @default.
- Q91754835 P50 Q91754835-CE842D1C-90CB-425C-8F9E-FA119C1E7EA4 @default.
- Q91754835 P50 Q91754835-D70B2FF0-3666-4B8F-ACB3-32077F6E8F5A @default.
- Q91754835 P50 Q91754835-E81F268F-4FE7-40F6-82B8-550324D6B000 @default.
- Q91754835 P577 Q91754835-37ECFFE1-4A47-490D-BF54-A31D28456872 @default.
- Q91754835 P698 Q91754835-15F54B7B-CD70-41E1-926D-C6DA9EDBDF72 @default.
- Q91754835 P921 Q91754835-13442E10-F5E4-4DFB-A076-83A577264EA7 @default.
- Q91754835 P921 Q91754835-6EAA56C7-C7F6-43DC-A008-12CFF54A88B8 @default.
- Q91754835 P921 Q91754835-7025EABC-7FF8-4565-BF00-FE6C6164BA3D @default.
- Q91754835 P356 S11060-019-03175-2 @default.
- Q91754835 P698 31054101 @default.
- Q91754835 P1433 Q15752119 @default.
- Q91754835 P1476 "Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial" @default.
- Q91754835 P2093 "Enrico Turco" @default.
- Q91754835 P2093 "Laura Masini" @default.
- Q91754835 P2093 "Ludovica Pegurri" @default.
- Q91754835 P304 "447-455" @default.
- Q91754835 P31 Q13442814 @default.
- Q91754835 P356 "10.1007/S11060-019-03175-2" @default.
- Q91754835 P433 "3" @default.
- Q91754835 P478 "143" @default.
- Q91754835 P50 Q38323481 @default.
- Q91754835 P50 Q38545600 @default.
- Q91754835 P50 Q38545618 @default.
- Q91754835 P50 Q38545627 @default.
- Q91754835 P50 Q57203625 @default.
- Q91754835 P50 Q57612084 @default.
- Q91754835 P50 Q80183145 @default.
- Q91754835 P50 Q82265629 @default.
- Q91754835 P50 Q88331427 @default.
- Q91754835 P50 Q88927157 @default.
- Q91754835 P50 Q90998025 @default.
- Q91754835 P50 Q91754819 @default.
- Q91754835 P50 Q91754823 @default.
- Q91754835 P50 Q91754828 @default.
- Q91754835 P50 Q91754831 @default.
- Q91754835 P577 "2019-05-04T00:00:00Z" @default.
- Q91754835 P698 "31054101" @default.
- Q91754835 P921 Q282142 @default.
- Q91754835 P921 Q425088 @default.
- Q91754835 P921 Q42824440 @default.